Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctionphosphatidylinositol phospholipase C activity

PLCB1 PLCB4

3.05e-0426202GO:0004435
GeneOntologyMolecularFunctionphospholipase C activity

PLCB1 PLCB4

3.81e-0429202GO:0004629
GeneOntologyMolecularFunctionnuclear estrogen receptor binding

PSMC3IP DNMT1

1.27e-0353202GO:0030331
GeneOntologyMolecularFunctioncatalytic activity, acting on DNA

FANCM CHD1 DNMT1

2.16e-03262203GO:0140097
GeneOntologyMolecularFunctionATP-dependent activity

FANCM ABCC11 ACSBG2 CHD1

2.90e-03614204GO:0140657
GeneOntologyMolecularFunctioncatalytic activity, acting on a nucleic acid

FANCM HARS2 CHD1 DNMT1

3.46e-03645204GO:0140640
GeneOntologyMolecularFunctionphosphatidylinositol-4,5-bisphosphate binding

PLCB1 OSBPL2

4.02e-0395202GO:0005546
GeneOntologyMolecularFunctionphosphoric diester hydrolase activity

PLCB1 PLCB4

4.19e-0397202GO:0008081
GeneOntologyCellularComponentperinuclear endoplasmic reticulum

FYN OSBPL2

3.48e-0429202GO:0097038
MousePhenoabnormal ovary morphology

ASPM FANCM PLCB1 PSMC3IP SPZ1

1.53e-04451175MP:0001126
MousePhenoabnormal internal female genitalia morphology

ASPM FANCM PLCB1 PSMC3IP SPZ1 PLCB4

1.83e-04757176MP:0009209
MousePhenoabnormal female genitalia morphology

ASPM FANCM PLCB1 PSMC3IP SPZ1 PLCB4

1.91e-04763176MP:0009208
MousePhenoabnormal female reproductive system morphology

ASPM FANCM PLCB1 PSMC3IP SPZ1 PLCB4

1.95e-04766176MP:0001119
MousePhenoabnormal female reproductive gland morphology

ASPM FANCM PLCB1 PSMC3IP SPZ1

1.96e-04475175MP:0013324
MousePhenoabnormal cell cycle

ASPM FANCM PSMC3IP RPL29 CHD1

2.98e-04520175MP:0003077
DomainPLC-beta_CS

PLCB1 PLCB4

3.27e-063202IPR009535
DomainDUF1154

PLCB1 PLCB4

3.27e-063202PF06631
DomainPLC-beta

PLCB1 PLCB4

6.53e-064202IPR016280
DomainPIPLC_Y_DOMAIN

PLCB1 PLCB4

1.13e-0415202PS50008
DomainPI-PLC_fam

PLCB1 PLCB4

1.13e-0415202IPR001192
DomainPLC_EF-hand-like

PLCB1 PLCB4

1.13e-0415202IPR015359
DomainPI-PLC-Y

PLCB1 PLCB4

1.13e-0415202PF00387
DomainPLipase_C_Pinositol-sp_Y

PLCB1 PLCB4

1.13e-0415202IPR001711
DomainEF-hand_like

PLCB1 PLCB4

1.13e-0415202PF09279
DomainPLCYc

PLCB1 PLCB4

1.13e-0415202SM00149
DomainPI-PLC-X

PLCB1 PLCB4

1.65e-0418202PF00388
DomainPLCXc

PLCB1 PLCB4

1.65e-0418202SM00148
DomainPIPLC_X_DOMAIN

PLCB1 PLCB4

1.84e-0419202PS50007
DomainPLipase_C_PInositol-sp_X_dom

PLCB1 PLCB4

1.84e-0419202IPR000909
Domain-

PLCB1 PLCB4

3.22e-04252023.20.20.190
DomainPLC-like_Pdiesterase_TIM-brl

PLCB1 PLCB4

3.22e-0425202IPR017946
DomainDNA/RNA_helicase_DEAH_CS

FANCM CHD1

6.35e-0435202IPR002464
DomainDEAH_ATP_HELICASE

FANCM CHD1

7.48e-0438202PS00690
Domain-

PLCB1 PLCB4 EFCAB13

2.58e-032612031.10.238.10
DomainEF-hand-dom_pair

PLCB1 PLCB4 EFCAB13

3.37e-03287203IPR011992
DomainHelicase_C

FANCM CHD1

5.78e-03107202PF00271
DomainHELICc

FANCM CHD1

5.78e-03107202SM00490
DomainHelicase_C

FANCM CHD1

5.88e-03108202IPR001650
DomainHELICASE_CTER

FANCM CHD1

5.99e-03109202PS51194
DomainHELICASE_ATP_BIND_1

FANCM CHD1

5.99e-03109202PS51192
DomainDEXDc

FANCM CHD1

5.99e-03109202SM00487
DomainHelicase_ATP-bd

FANCM CHD1

6.09e-03110202IPR014001
DomainC2

PLCB1 PLCB4

8.54e-03131202PF00168
DomainC2

PLCB1 PLCB4

9.31e-03137202SM00239
DomainC2

PLCB1 PLCB4

9.97e-03142202PS50004
Domain-

PLCB1 PLCB4

1.08e-021482022.60.40.150
DomainP-loop_NTPase

ASPM FANCM ABCC11 CHD1

1.14e-02848204IPR027417
PathwayKEGG_MEDICUS_PATHOGEN_HCMV_UL33_TO_GNAQ_PLCB_G_CALCINEURIN_SIGNALING_PATHWAY

PLCB1 PLCB4

1.58e-056152M47548
PathwayKEGG_MEDICUS_REFERENCE_CASR_PTH_SIGNALING_PATHWAY

PLCB1 PLCB4

2.21e-057152M47505
PathwayKEGG_MEDICUS_REFERENCE_TAC3_TACR3_PLC_PKC_SIGNALING_PATHWAY

PLCB1 PLCB4

4.73e-0510152M47644
PathwayKEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SPTBN2_TO_MGLUR1_TRPC3_SIGNALING_PATHWAY

PLCB1 PLCB4

4.73e-0510152M47661
PathwayKEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_PRKCG_TO_MGLUR1_TRPC3_SIGNALING_PATHWAY

PLCB1 PLCB4

5.78e-0511152M49033
PathwayKEGG_MEDICUS_REFERENCE_KISS1_KISS1R_PLCB_PKC_SIGNALING_PATHWAY

PLCB1 PLCB4

5.78e-0511152M47637
PathwayKEGG_MEDICUS_REFERENCE_TRH_TRHR_PLCB_PKC_SIGNALING_PATHWAY

PLCB1 PLCB4

6.93e-0512152M47649
PathwayKEGG_MEDICUS_REFERENCE_TSH_DUOX2_TG_SIGNALING_PATHWAY

PLCB1 PLCB4

6.93e-0512152M47628
PathwayKEGG_MEDICUS_REFERENCE_MGLUR1_TRPC3_SIGNALING_PATHWAY

PLCB1 PLCB4

8.19e-0513152M47656
PathwayKEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABBERANT_ATXN2_3_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY

PLCB1 PLCB4

1.60e-0418152M47659
PathwayKEGG_MEDICUS_REFERENCE_CXCL12_CXCR4_PKC_ERK_SIGNALING_PATHAWAY

PLCB1 PLCB4

1.79e-0419152M47596
PathwayKEGG_MEDICUS_PATHOGEN_HCMV_US28_TO_GNAQ_PLCB_G_CALCINEURIN_SIGNALING_PATHWAY

PLCB1 PLCB4

1.79e-0419152M47543
PathwayKEGG_MEDICUS_REFERENCE_MACHR_CA2_APOPTOTIC_PATHWAY

PLCB1 PLCB4

1.99e-0420152M47688
PathwayKEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_MACHR_CA2_APOPTOTIC_PATHWAY

PLCB1 PLCB4

2.19e-0421152M47689
PathwayKEGG_MEDICUS_REFERENCE_GNRH_GNRHR_PLCB_PKC_SIGNALING_PATHWAY

PLCB1 PLCB4

2.19e-0421152M47638
PathwayKEGG_MEDICUS_REFERENCE_CXCR4_GNAQ_PLCB_G_CALCINEURIN_SIGNALING_PATHWAY

PLCB1 PLCB4

2.19e-0421152M47542
PathwayWP_PKCGAMMA_CALCIUM_SIGNALING_IN_ATAXIA

PLCB1 PLCB4

2.41e-0422152M39795
PathwayKEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY

PLCB1 PLCB4

2.41e-0422152M47690
PathwayKEGG_MEDICUS_REFERENCE_MGLUR5_CA2_APOPTOTIC_PATHWAY

PLCB1 PLCB4

2.41e-0422152M47675
PathwayKEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY

PLCB1 PLCB4

2.64e-0423152M47676
PathwayKEGG_MEDICUS_REFERENCE_CCR5_GNB_G_PLCB_G_PKC_SIGNALING_PATHWAY

PLCB1 PLCB4

3.38e-0426152M47557
PathwayREACTOME_SYNTHESIS_OF_IP3_AND_IP4_IN_THE_CYTOSOL

PLCB1 PLCB4

3.38e-0426152M27053
PathwayREACTOME_SYNTHESIS_OF_IP3_AND_IP4_IN_THE_CYTOSOL

PLCB1 PLCB4

3.93e-0428152MM14711
PathwayKEGG_MEDICUS_REFERENCE_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY

PLCB1 PLCB4

3.93e-0428152M47508
PathwayWP_GPR143_IN_MELANOCYTES_AND_RETINAL_PIGMENT_EPITHELIUM_CELLS

PLCB1 PLCB4

4.52e-0430152M42578
PathwayKEGG_MEDICUS_REFERENCE_CXCR4_GNB_G_PLCB_PKC_SIGNALING_PATHWAY

PLCB1 PLCB4

4.83e-0431152M47554
PathwayWP_RESISTIN_AS_A_REGULATOR_OF_INFLAMMATION

PLCB1 PLCB4

5.47e-0433152M39745
PathwayWP_PRIMARY_OVARIAN_INSUFFICIENCY

FANCM PSMC3IP HARS2

7.54e-04174153M48058
PathwayWP_KISSPEPTINKISSPEPTIN_RECEPTOR_SYSTEM_IN_THE_OVARY

PLCB1 PLCB4

7.65e-0439152M39905
PathwayREACTOME_G_PROTEIN_MEDIATED_EVENTS

PLCB1 PLCB4

7.65e-0439152MM14496
PathwayWP_PHOSPHATIDYL_INOSITOL_PHOSPHATE_PATHWAY

PLCB1 PLCB4

1.06e-0346152M48317
PathwayREACTOME_INOSITOL_PHOSPHATE_METABOLISM

PLCB1 PLCB4

1.16e-0348152MM14589
PathwayREACTOME_INOSITOL_PHOSPHATE_METABOLISM

PLCB1 PLCB4

1.16e-0348152M26964
PathwayWP_PHOSPHOINOSITIDES_METABOLISM

PLCB1 PLCB4

1.21e-0349152M40046
PathwayKEGG_MEDICUS_REFERENCE_GPCR_PLCB_ITPR_SIGNALING_PATHWAY

PLCB1 PLCB4

1.26e-0350152M47951
PathwayKEGG_INOSITOL_PHOSPHATE_METABOLISM

PLCB1 PLCB4

1.46e-0354152M3896
PathwayREACTOME_G_PROTEIN_MEDIATED_EVENTS

PLCB1 PLCB4

1.46e-0354152M26911
PathwayKEGG_LONG_TERM_POTENTIATION

PLCB1 PLCB4

2.45e-0370152M3115
PathwayKEGG_LONG_TERM_DEPRESSION

PLCB1 PLCB4

2.45e-0370152M8232
PathwayREACTOME_OPIOID_SIGNALLING

PLCB1 PLCB4

2.52e-0371152MM14491
PathwayWP_ALZHEIMERS_DISEASE

PLCB1 PLCB4

2.73e-0374152MM15962
PathwayWP_NONGENOMIC_ACTIONS_OF_125_DIHYDROXYVITAMIN_D3

PLCB1 PLCB4

2.80e-0375152M39568
PathwayKEGG_PHOSPHATIDYLINOSITOL_SIGNALING_SYSTEM

PLCB1 PLCB4

2.88e-0376152M9052
PathwayWP_IL2_SIGNALING_PATHWAY

PLCB1 FYN

3.75e-0387152MM15915
PathwayKEGG_GAP_JUNCTION

PLCB1 PLCB4

4.01e-0390152M4013
PathwayREACTOME_OPIOID_SIGNALLING

PLCB1 PLCB4

4.01e-0390152M6467
PathwayWP_HIPPO_SIGNALING_REGULATION

PLCB1 PLCB4

4.74e-0398152M39830
PathwayPID_CXCR4_PATHWAY

PLCB1 FYN

4.93e-03100152M124
PathwayKEGG_MELANOGENESIS

PLCB1 PLCB4

5.02e-03101152M7761
PathwayKEGG_GNRH_SIGNALING_PATHWAY

PLCB1 PLCB4

5.02e-03101152M1979
Pubmed

Phospholipase C-β1 and β4 contribute to non-genetic cell-to-cell variability in histamine-induced calcium signals in HeLa cells.

PLCB1 PLCB4

3.47e-07221224475116
Pubmed

Genetic variants in PLCB4/PLCB1 as susceptibility loci for coronary artery aneurysm formation in Kawasaki disease in Han Chinese in Taiwan.

PLCB1 PLCB4

3.47e-07221226434682
Pubmed

Phospholipase Cbeta serves as a coincidence detector through its Ca2+ dependency for triggering retrograde endocannabinoid signal.

PLCB1 PLCB4

3.47e-07221215664177
Pubmed

Differential distribution of phospholipase C beta isoforms and diaglycerol kinase-beta in rodents cerebella corroborates the division of unipolar brush cells into two major subtypes.

PLCB1 PLCB4

1.04e-06321223503970
Pubmed

Primary phospholipase C and brain disorders.

PLCB1 PLCB4

1.04e-06321226639088
Pubmed

Patterns of expression for the mRNA corresponding to the four isoforms of phospholipase Cbeta in mouse brain.

PLCB1 PLCB4

2.08e-0642129753089
Pubmed

Phospholipase C-β1 potentiates glucose-stimulated insulin secretion.

PLCB1 PLCB4

2.08e-06421231268747
Pubmed

PLCβ isoforms differ in their subcellular location and their CT-domain dependent interaction with Gαq.

PLCB1 PLCB4

2.08e-06421223006664
Pubmed

Phospholipase C isozymes selectively couple to specific neurotransmitter receptors.

PLCB1 PLCB4

2.08e-0642129305844
Pubmed

Expression of phospholipase C beta family isoenzymes in C2C12 myoblasts during terminal differentiation.

PLCB1 PLCB4

2.08e-06421215174099
Pubmed

Expression and immunohistochemical localization of eight phospholipase C isoforms in adult male mouse cerebellar cortex.

PLCB1 PLCB4

5.20e-0662128739298
Pubmed

Purification and characterization of membrane-bound phospholipase C specific for phosphoinositides from human platelets.

PLCB1 PLCB4

5.20e-0662122841328
Pubmed

Genetic dissection of gustatory sensitivity to bitterness (sucrose octaacetate) in mice.

PLCB1 PLCB4

7.28e-06721210609087
Pubmed

Exogenous human immunodeficiency virus type-1 Tat protein selectively stimulates a phosphatidylinositol-specific phospholipase C nuclear pathway in the Jurkat T cell line.

PLCB1 PLCB4

1.25e-0592127589147
Pubmed

Phospholipase C-beta 1 is a GTPase-activating protein for Gq/11, its physiologic regulator.

PLCB1 PLCB4

1.25e-0592121322796
Pubmed

Involvement of inositol 1,4,5-trisphosphate-regulated stores of intracellular calcium in calcium dysregulation and neuron cell death caused by HIV-1 protein tat.

PLCB1 PLCB4

1.25e-05921210501179
Pubmed

Implantation failure in mice with a disruption in Phospholipase C beta 1 gene: lack of embryonic attachment, aberrant steroid hormone signalling and defective endocannabinoid metabolism.

PLCB1 PLCB4

1.56e-051021223295235
Pubmed

Expression of phospholipase C isozymes by murine B lymphocytes.

PLCB1 PLCB4

1.56e-05102122033248
Pubmed

Synergistic Signaling by Light and Acetylcholine in Mouse Iris Sphincter Muscle.

PLCB1 PLCB4

3.63e-051521228578927
Pubmed

Cloning and characterization of the human phosphoinositide-specific phospholipase C-beta 1 (PLC beta 1).

PLCB1 PLCB4

3.63e-051521211118617
Pubmed

Human immunodeficiency virus-1 glycoproteins gp120 and gp160 specifically inhibit the CD3/T cell-antigen receptor phosphoinositide transduction pathway.

PLCB1 PLCB4

5.28e-05182121979339
Pubmed

Cyclic-Nucleotide- and HCN-Channel-Mediated Phototransduction in Intrinsically Photosensitive Retinal Ganglion Cells.

PLCB1 PLCB4

7.24e-052121230270038
Pubmed

Polymorphisms in innate immunity genes and patients response to dendritic cell-based HIV immuno-treatment.

PLCB1 FYN PLCB4

8.22e-0514121320056178
Pubmed

HIV-1 tat molecular diversity and induction of TNF-alpha: implications for HIV-induced neurological disease.

PLCB1 PLCB4

8.72e-05232129730685
Pubmed

The Tat protein of HIV-1 induces tumor necrosis factor-alpha production. Implications for HIV-1-associated neurological diseases.

PLCB1 PLCB4

8.72e-05232129278385
Pubmed

Release of calcium from inositol 1,4,5-trisphosphate receptor-regulated stores by HIV-1 Tat regulates TNF-alpha production in human macrophages.

PLCB1 PLCB4

9.51e-052421210843712
Pubmed

A novel p53 regulator, C16ORF72/TAPR1, buffers against telomerase inhibition.

PLCB1 HARS2 FAM111B OSBPL2

1.18e-0443121433660365
Pubmed

Mechanism of HIV-1-TAT induction of interleukin-1beta from human monocytes: Involvement of the phospholipase C/protein kinase C signaling cascade.

PLCB1 PLCB4

1.21e-042721220336759
Pubmed

Genetic mapping of the human and mouse phospholipase C genes.

PLCB1 PLCB4

1.81e-04332128672127
Pubmed

Identification of the BRD1 interaction network and its impact on mental disorder risk.

QSER1 DNMT1

2.04e-043521227142060
Pubmed

Signaling pathways triggered by HIV-1 Tat in human monocytes to induce TNF-alpha.

PLCB1 PLCB4

2.41e-043821212482669
Pubmed

The in vivo Interaction Landscape of Histones H3.1 and H3.3.

ZNF462 CHD1 QSER1 DNMT1

4.37e-0460821436089195
Pubmed

A genome-wide study of common SNPs and CNVs in cognitive performance in the CANTAB.

PLCB1 SEC14L1

5.62e-045821219734545
Cytoband20p12

PLCB1 PLCB4

1.81e-051421220p12
CytobandEnsembl 112 genes in cytogenetic band chr20p12

PLCB1 PLCB4

1.38e-03120212chr20p12
GeneFamilyPhospholipases|C2 domain containing phospholipases

PLCB1 PLCB4

1.09e-0419152832
GeneFamilyPhospholipases

PLCB1 PLCB4

5.43e-0442152467
ToppCellNeuron-Postmitotic-Excitatory_Neuron_-IPC/newborn-38|World / Primary Cells by Cluster

ZNF462 PLCB1 FYN PLCB4 QSER1

2.87e-0819621538da0751941adca650fe9b383d9f343153978eb5
ToppCellNeuron-Postmitotic-Excitatory_Neuron_-IPC/newborn|World / Primary Cells by Cluster

ZNF462 PLCB1 FYN PLCB4 QSER1

2.87e-08196215721650a08d260faf530dbd52d4e9275d27f3bac2
ToppCell3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_T/NK-T_cell-T_cells_proliferating-T_cells_proliferating_L.1.1.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

ASPM FYN DNMT1 FAM111B

1.53e-061842148260e688ec42a1374727bc85dceb7edd19a8b662
ToppCellCOVID-19-lung-Artery_EC|lung / Disease (COVID-19 only), tissue and cell type

PLCB1 FYN PLCB4 SEC14L1

1.67e-06188214eecd7482b3c97d7f49993cb17edfab30c61232fc
ToppCellPBMC-Mild-cDC_12|Mild / Compartment, Disease Groups and Clusters

ASPM PSMC3IP ABCC11 FAM111B

1.71e-06189214946c95d2ecc36b241f58e8c4ad6455fe47c762fa
ToppCellIPF-Myeloid-cMonocyte|Myeloid / Disease state, Lineage and Cell class

PLCB1 FYN CHD1 SEC14L1

1.71e-06189214ad7bb3a7de8e48c145e4382f90d30bb2159c2b76
ToppCellIPF-Myeloid-ncMonocyte|Myeloid / Disease state, Lineage and Cell class

PLCB1 FYN CHD1 SEC14L1

1.71e-061892145c22d2d935f7bb270260b8bc6be67b565ec401bf
ToppCellCOPD-Myeloid-ncMonocyte|World / Disease state, Lineage and Cell class

PLCB1 FYN CHD1 SEC14L1

1.74e-06190214aece860b5609ad5a8fc920d685f0d0ec71bf9018
ToppCellCOPD-Myeloid-ncMonocyte|Myeloid / Disease state, Lineage and Cell class

PLCB1 FYN CHD1 SEC14L1

1.74e-06190214ed978cd5d9da87b49878a330e362762c487f849f
ToppCellCOVID-19-lung-Artery_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type

PLCB1 FYN PLCB4 SEC14L1

1.74e-0619021407b675befcd1d0a9c90cb17b5d22323468325d51
ToppCellCOVID-19-kidney-AQP1+SLC14A1+EC|kidney / Disease (COVID-19 only), tissue and cell type

PLCB1 FYN PLCB4 SEC14L1

1.74e-061902141519f34d31fe0817184c5865a0bc9f0cb479b1a4
ToppCellControl-Myeloid-ncMonocyte|Myeloid / Disease state, Lineage and Cell class

PLCB1 FYN CHD1 SEC14L1

1.86e-061932143479c01aaae7afd7e02d00e0cb21951c0106a0fd
ToppCell3'_v3-blood-Lymphocytic_NK-Cycling_NK|blood / Manually curated celltypes from each tissue

ASPM PSMC3IP DNMT1 FAM111B

1.89e-06194214bf9734abaad603ade2a6a6940918aaf1e1c4e2cd
ToppCellControl-Myeloid-ncMonocyte|Control / Disease state, Lineage and Cell class

PLCB1 FYN CHD1 SEC14L1

1.93e-06195214fcb05948e7480dc53f06f3fc9b9c3fc129874edd
ToppCellbackground-Endothelial_cells|background / Sample and Cell Type and Tumor Cluster (all cells)

ZNF462 PLCB1 FYN SEC14L1

1.97e-06196214e6fb0bfab1779ec64a8c35d01519eaafbf62e977
ToppCell10x5'-blood-Lymphocytic_T_CD4/8-lo|blood / Manually curated celltypes from each tissue

ASPM PSMC3IP DNMT1 FAM111B

2.01e-06197214acd678586aa0e4375bc8fbcdaa1a796c8dd23885
ToppCell10x5'-blood-Lymphocytic_T_CD4/8-lo-Cycling_T|blood / Manually curated celltypes from each tissue

ASPM PSMC3IP DNMT1 FAM111B

2.01e-061972141f7c3d193647b66cce6ea202a40758cd10b8bd12
ToppCellParenchymal-NucSeq-Endothelial-Endothelia_vascular-VE_capillary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

PLCB1 FYN PLCB4 SEC14L1

2.05e-061982141d30a1f73b6d6d838f49751402a29c5ef54aa81f
ToppCellParenchymal-NucSeq-Endothelial-Endothelia_vascular-VE_pulmonary_arterial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

PLCB1 FYN PLCB4 SEC14L1

2.05e-06198214002424b24dacac553e02d0f764a6e8a1e567b9df
ToppCellCOVID-19-lung-Capillary_2|lung / Disease (COVID-19 only), tissue and cell type

PLCB1 FYN PLCB4 SEC14L1

2.10e-06199214793ce71b78a68033ef4419ed571e1dd86b40124f
ToppCellParenchymal-NucSeq-Endothelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

PLCB1 FYN PLCB4 SEC14L1

2.10e-06199214a4a9a1c2a34b5a8318a55d1211d6c8661ca9793e
ToppCellParenchymal-NucSeq-Endothelial-Endothelia_vascular|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

PLCB1 FYN PLCB4 SEC14L1

2.10e-06199214d58edc5f74970bb26d844746184e4bae7c494d6b
ToppCell356C-Lymphocytic-NK_cells-Proliferating_NK_cell|NK_cells / Donor, Lineage, Cell class and subclass (all cells)

ASPM PSMC3IP DNMT1 FAM111B

2.14e-0620021497e47eb69d1d4cab45256acca9589837eb7817e7
ToppCellBrain_organoid-organoid_Tanaka_cellReport-6m-Stem_cells-Neuroepithelial_cell|6m / Sample Type, Dataset, Time_group, and Cell type.

ASPM PSMC3IP DNMT1 FAM111B

2.14e-0620021455501f83409e0174c756a13ad8077f5b59975e27
ToppCellBrain_organoid-organoid_Tanaka_cellReport-6m-Stem_cells|6m / Sample Type, Dataset, Time_group, and Cell type.

ASPM PSMC3IP DNMT1 FAM111B

2.14e-06200214b9aad527d3ad5bc701e93fa2afdebf695b2a74bb
ToppCell356C-Myeloid-Dendritic-cDC_proliferating_1|Myeloid / Donor, Lineage, Cell class and subclass (all cells)

ASPM PSMC3IP DNMT1 FAM111B

2.14e-062002145b014c658eecc5e73679e5feb7a2aaa3d297001d
ToppCellAdult-Mesenchymal-airway_smooth_muscle_cell-D122|Adult / Lineage, Cell type, age group and donor

PLCB1 ACSBG2 PLCB4

5.71e-0516121364891f6f2ee1693c8481e951b9346e2f92d602e3
ToppCellChildren_(3_yrs)-Endothelial-endothelial_cell_of_bronchial_vessel|Children_(3_yrs) / Lineage, Cell type, age group and donor

PLCB1 PLCB4 CCDC178

5.92e-05163213977a970b1296234c22178420294cea73506ee02f
ToppCell367C-Lymphocytic-CD4_T-cell-Proliferating_T_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)

ASPM PSMC3IP FAM111B

6.03e-05164213fb18b863152fb3109e2224c791c84c6371680a4e
ToppCellEndothelial-endothelial_cell_of_bronchial_vessel|World / Lineage, Cell type, age group and donor

PLCB1 PLCB4 CCDC178

6.14e-0516521384e553d699ac56df89a77248f7308b9133e1b683
ToppCellDividing_Macrophages-Donor_06|World / lung cells shred on cell class, cell subclass, sample id

ASPM PSMC3IP FAM111B

6.25e-05166213ea95b94ccc2ac67df741b30c27f4ae698925875f
ToppCell343B-Lymphocytic-NK_cells-Proliferating_NK_cell|343B / Donor, Lineage, Cell class and subclass (all cells)

ASPM PSMC3IP FAM111B

6.59e-0516921302fa66a91b8bd2bf971aec4f5ec58318b5bfdf14
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

ASPM DNMT1 FAM111B

6.59e-05169213b253a4a50c06d36228fcd5d856c57202cbac158f
ToppCellControl-Endothelial_cells-Systemic_venous_endothelial_cells|Control / group, cell type (main and fine annotations)

PLCB1 PLCB4 CCDC178

6.94e-05172213c55dce1ed3ed7312394b4e050e1de852a994e130
ToppCell367C-Lymphocytic-CD4_T-cell-Proliferating_T_cell|367C / Donor, Lineage, Cell class and subclass (all cells)

ASPM PSMC3IP FAM111B

6.94e-051722138d20eda599abf1e9e3e3b90f314acddee6a465a4
ToppCell10x5'-bone_marrow-Lymphocytic_NK-Cycling_NK|bone_marrow / Manually curated celltypes from each tissue

ASPM DNMT1 FAM111B

7.06e-051732138a9dd85f718564c07cf3120ad648daeb60c94fc5
ToppCell368C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)

ASPM QSER1 FAM111B

7.06e-0517321320889aa85e36ad3bafdb91b91e43964493c949f9
ToppCell368C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)

ASPM QSER1 FAM111B

7.06e-0517321346e601b7938b1dd0aa3df7aa056c4bd07b1620c1
ToppCellIPF-Lymphoid-ILC_A|Lymphoid / Disease state, Lineage and Cell class

PLCB1 FYN SEC14L1

7.31e-05175213b6d1e40d9339426d778481fd67ab7cbc0f6cb5b2
ToppCell367C-Myeloid-Dendritic-cDC_proliferating_1|Myeloid / Donor, Lineage, Cell class and subclass (all cells)

ASPM PSMC3IP FAM111B

7.31e-051752136b4e841bde6cfa4956e1a0231672cea20f11210c
ToppCell3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-CD8-positive,_alpha-beta_T_cell-CD8_T_cells-CD8_T_cells_L.1.1.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

ASPM FYN FAM111B

7.68e-05178213c4a2e9a440e941e82bb35abefa054e07ad250d45
ToppCell343B-Lymphocytic-NK_cells-Proliferating_NK_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)

ASPM PSMC3IP FAM111B

7.68e-05178213c7e890cd02206c516cf1d7692ea7abc8ce746482
ToppCellCOVID-19-kidney-AQP1+SLC14A1+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type

PLCB1 PLCB4 SEC14L1

7.81e-051792131ce8d18f63e8dd2d3db41fbeca4601bd3b305fba
ToppCell10x5'-blood-Lymphocytic_NK-Cycling_NK|blood / Manually curated celltypes from each tissue

ASPM PSMC3IP FAM111B

7.81e-05179213c93711273055a999335ba8d0f6500e4549f46cec
ToppCellCOVID-19-Heart-EC_2|COVID-19 / Disease (COVID-19 only), tissue and cell type

PLCB1 PLCB4 SEC14L1

7.81e-051792132a53d94f6c30bf887dfe88f1693ea057218c852d
ToppCellCOVID-19-kidney-PLVAP+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type

PLCB1 FYN SEC14L1

7.94e-05180213493cf8d1a8f2a1ed2672f394a0338b110fd81d88
ToppCellIIH-cycling-|IIH / Condition, Cell_class and T cell subcluster

ASPM PSMC3IP FAM111B

8.07e-051812137f4fed9e296bc22cb5a1e6c8e3c4b641e97c3078
ToppCellIIH-cycling|IIH / Condition, Cell_class and T cell subcluster

ASPM PSMC3IP FAM111B

8.07e-05181213ec3e782ce93dcfe1a54fb7284e4e39063614b0e2
ToppCell3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells-NK_cells_L.1.3.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

ASPM PSMC3IP FAM111B

8.07e-05181213e4dbc09f0210de465d8347969b301c22463a2b7d
ToppCellHealthy_Control-Lymphoid-T-|Healthy_Control / Condition, Lineage, Cell class and cell subclass

ASPM PSMC3IP FAM111B

8.07e-05181213ac1ee313910c05b1b3cb497bae14565464919c21
ToppCellCOVID-19-Endothelial_cells-Endothelial_cells_(other)|COVID-19 / group, cell type (main and fine annotations)

PLCB1 PLCB4 SEC14L1

8.07e-0518121326eb4ee57a70dbf54e096b73129fda9dfda1f6ec
ToppCell5'-Adult-LymphNode-Epithelial-epithelial_progenitor_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

PSMC3IP RPL29 FAM111B

8.21e-05182213cf0a6f99b825eb75f95f376c16a504e2669820ac
ToppCell343B-Lymphocytic-NK_cells-Proliferating_NK_cell|NK_cells / Donor, Lineage, Cell class and subclass (all cells)

ASPM PSMC3IP FAM111B

8.21e-05182213b1e66ccd5f33b4801f1cafddf97f5fc0c6dba8d1
ToppCellCOVID-19-kidney-Mito-rich_EC|kidney / Disease (COVID-19 only), tissue and cell type

PLCB1 FYN SEC14L1

8.34e-051832133c4153479fc4ab2d073d92cee120480015555914
ToppCellControl-T/NK-proliferating_T/NK|Control / Disease group,lineage and cell class （2021.01.30）

ASPM ZNF462 FAM111B

8.34e-05183213e740f05536d1e4b2512811771928eb65f6696409
ToppCellCOVID-19-Endothelial_cells-Arterial_endothelial_cells|COVID-19 / group, cell type (main and fine annotations)

PLCB1 PLCB4 SEC14L1

8.48e-051842130f19494789f38ab1a420545e15e748ca7eb345c3
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

PLCB1 CCDC178 SEC14L1

8.48e-051842138fd8bd3d28d0ee6f0ef1f14e354d8eaf63a8081b
ToppCellCOVID-19-Endothelial_cells-Systemic_venous_endothelial_cells|COVID-19 / group, cell type (main and fine annotations)

PLCB1 PLCB4 SEC14L1

8.61e-05185213f5e14181f45c37d13ee9e017a4c8bc248c353676
ToppCellControl-Endothelial_cells-Endothelial_cells_(other)|Control / group, cell type (main and fine annotations)

FYN PLCB4 SEC14L1

8.75e-05186213c6075fe84226b370c5139066793844ad33ae2db1
ToppCellfacs-Large_Intestine-Proximal-3m-Epithelial-epithelial_cell_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ASPM RPL29 DNMT1

8.75e-051862134ed1b97e2552f3c4134f25665d7513498ffac16c
ToppCellfacs-Large_Intestine-Proximal-3m-Epithelial-Lgr5-_amplifying_undifferentiated_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ASPM RPL29 DNMT1

8.75e-0518621315ab6666748a641226e42e6ca6eeaf186a501c95
ToppCellCOVID-19-Heart-EC_2|Heart / Disease (COVID-19 only), tissue and cell type

PLCB1 PLCB4 SEC14L1

8.89e-0518721340ffc06a3e3251d9b12da390210d3e045af7537a
ToppCellControl-Endothelial_cells-Endothelial_cells_(general)|Control / group, cell type (main and fine annotations)

FYN PLCB4 SEC14L1

8.89e-05187213fb5bcbc8effdbf0e57fcb71aca990a4aa0d65ce8
ToppCellControl-Endothelial_cells-Arterial_endothelial_cells|Control / group, cell type (main and fine annotations)

PLCB1 PLCB4 SEC14L1

8.89e-0518721381affaab3fe3e1daea45ada6445e906ddd33950e
ToppCellAdult-Endothelial-capillary_endothelial_cell_(Cap1)-D122|Adult / Lineage, Cell type, age group and donor

FYN PLCB4 SEC14L1

9.03e-0518821302a62888e9db29d20133eeca1686d302545a39c9
ToppCellControl-Myeloid-cMonocyte|Myeloid / Disease state, Lineage and Cell class

PLCB1 FYN CHD1

9.03e-0518821347126c371a242c937499fd278a74a882df8f759c
ToppCell367C-Lymphocytic-CD4_T-cell-Proliferating_T_cell|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells)

ASPM PSMC3IP FAM111B

9.03e-05188213f5102e8d95506c25c675094b86162a6a50087b64
ToppCellChildren_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor

PLCB1 PLCB4 SEC14L1

9.03e-05188213117dc80fa940e6aa1b0187a43fdde33f3fcb578f
ToppCellCOVID-19-kidney-T-cells-2|COVID-19 / Disease (COVID-19 only), tissue and cell type

ASPM FYN FAM111B

9.03e-0518821315484c05cb496cd98ed3f79a6134c5cec8f09a4d
ToppCellBronchial-NucSeq-Immune_Lymphocytic-T-T_CD8-MAIT|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

PLCB1 FYN RPL29

9.18e-05189213159b0979c93b7d98aaeeb43fba5983a9f67b9c9d
ToppCellrenal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

PLCB1 PLCB4 SEC14L1

9.18e-051892138c8ca3b30d9be6c854615459a7bfba82b427c8bc
ToppCellCOPD-Myeloid-cMonocyte|Myeloid / Disease state, Lineage and Cell class

PLCB1 FYN CHD1

9.18e-051892136294691231c7d38707323cf31578a107d3b2c622
ToppCellrenal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

PLCB1 PLCB4 SEC14L1

9.18e-051892135d902a4660a27548764bf04c6de152b565da835c
ToppCellEndothelial-A-IPF_01|World / lung cells shred on cell class, cell subclass, sample id

PLCB1 PLCB4 CCDC178

9.18e-0518921304b565855f58ca0f343904d04be657b66e109076
ToppCell10x5'-lymph-node_spleen-Lymphocytic_Invariant-Inducer-like|lymph-node_spleen / Manually curated celltypes from each tissue

PLCB1 FYN PLCB4

9.32e-051902130c7eb8f4f2926af01bf44d5c9f239be7b81c67fe
ToppCellCOVID-19-Endothelial_cells-Endothelial_cells_(general)|COVID-19 / group, cell type (main and fine annotations)

PLCB1 PLCB4 SEC14L1

9.32e-05190213812e11314c76c0179fbe5a9bea29b41ce5cbc93d
ToppCellCOVID-19-lung-Vein_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type

PLCB1 FYN PLCB4

9.32e-051902131caeaef78326734c1e31a0c4739190d5c5a77b9e
ToppCellkidney_cells-Adult_normal_reference-Immune-Lymphocytic_T/NK-Cycling_Natural_Killer_Cell_/_Natural_Killer_T_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

ASPM DNMT1 FAM111B

9.32e-05190213b65383e256b04122500b742caeed0b807793851e
ToppCellIPF-Myeloid-ncMonocyte|World / Disease state, Lineage and Cell class

FYN CHD1 SEC14L1

9.32e-05190213f9c2a13c7f6460e3b348581be855b7281c8f70b5
ToppCellCOVID-19-Endothelial_cells|COVID-19 / group, cell type (main and fine annotations)

PLCB1 PLCB4 SEC14L1

9.32e-051902139fbd92cd6d4683b2490504d29c43cf42020433d4
ToppCellkidney_cells-Adult_normal_reference-Immune-Lymphocytic_T/NK-Cycling_Natural_Killer_Cell_/_Natural_Killer_T_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

ASPM DNMT1 FAM111B

9.32e-0519021389095d3e023269d89c82e3a73550f869e3f34201
ToppCellCOVID-19-kidney-VWF+PLVAP+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type

PLCB1 FYN SEC14L1

9.47e-051912132f00d0b7b2ffce8eb3eb5bbae49a0d425b23c982
ToppCell10x_3'_v2v3-Neoplastic-Differentiated-like-AC-like-AC-like_Prolif-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

ASPM DNMT1 FAM111B

9.47e-05191213588015d76b68488da6aa6603777682f3d81592bf
ToppCellCOVID-19-kidney-T-cells-2|kidney / Disease (COVID-19 only), tissue and cell type

ASPM FYN FAM111B

9.47e-05191213698e6a28276704f8baa082d028db2345b973c4bc
ToppCell356C-Myeloid-Macrophage-FABP4+_Macrophage_proliferating_2|356C / Donor, Lineage, Cell class and subclass (all cells)

ASPM PSMC3IP FAM111B

9.47e-05191213a2c235a55094e4fd5273d764c9e2967116b48c23
ToppCell3'-GW_trimst-2-LargeIntestine-Mesenchymal-immature_mesenchymal_cell-cycling_stromal|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

ASPM DNMT1 FAM111B

9.47e-0519121350854384fdaa0efa2e3227659d544ed09ac102f2
ToppCellrenal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

ZNF462 PLCB1 EFCAB13

9.47e-05191213d0e9afe7b6334dd515d3e68892efdc76347a55e5
ToppCell3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_proliferating-Alveolar_macrophage_proliferating_L.1.0.7.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

ASPM DNMT1 FAM111B

9.47e-05191213d6e158f16a183c9203c057192342e9b83e79bc89
ToppCell3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_proliferating|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

ASPM DNMT1 FAM111B

9.47e-051912137cb5c6f2cf27f3503d1b313e402a7410dfe6473e
ToppCelltumor_Lung-T/NK_cells-Exhausted_Tfh|tumor_Lung / Location, Cell class and cell subclass

FYN ZC3H8 CHD1

9.47e-051912133e259eba83f8159d1a1a96b98d0e867fe547c5e7
ToppCell3'-Distal_airway-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_proliferating-Alveolar_macrophage_proliferating_L.1.0.7.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

ASPM PSMC3IP FAM111B

9.47e-05191213b85a0978dc1e8af4f49423f56dcfd52efce09ed1
ToppCell(3)_Macrophage_Dividing|World / Lung cell shreds - cell class (v4) and cell subclass (v4)

ASPM PSMC3IP FAM111B

9.47e-05191213b42f0b89bb94fd43786ff50f1caeb3ebfbbb43fd
ToppCellCF-Myeloid-Monocyte|Myeloid / Disease state, Lineage and Cell class

PLCB1 FYN RPL29

9.62e-05192213da55719454b800b7e0cd6d5afd6332ecc5553218
ToppCellIPF-Myeloid-ncMonocyte|IPF / Disease state, Lineage and Cell class

FYN CHD1 SEC14L1

9.62e-05192213e9fb8c57d8094f70fb492909b2bec40aa5f2e5b8
ToppCellBrain_organoid-organoid_Paulsen_bioRxiv-3.5_mon-IPC_like|3.5_mon / Sample Type, Dataset, Time_group, and Cell type.

FYN PLCB4 QSER1

9.76e-05193213f24bae40f5cbcfece04fbefe4e3de1b88ac90de4
ToppCellLPS-IL1RA+antiTNF-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

PLCB1 FYN PLCB4

9.76e-05193213e09387af84d2a0a526e54d4793e6e06c6739db53
ToppCellLPS-antiTNF-Endothelial-Endothelial-Gen_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

PLCB1 FYN PLCB4

9.76e-051932136e1982d089a9de628e6006d23ff78a223fbd9f47
ToppCellcontrol-T/NK_proliferative|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

ASPM PSMC3IP FAM111B

9.76e-05193213ecb4018a47d9a82bb999e0bc8b3dceabd97d1f0d
ToppCell3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_T/NK-T_cell-T_cells_proliferating-T_cells_proliferating_L.1.1.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

ASPM DNMT1 FAM111B

9.76e-05193213b835d28de9daeec5213172c96f62b332cda53bb5
ToppCell10x_3'_v2v3-Neoplastic-Differentiated-like-AC-like-AC-like_Prolif-A|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

ASPM PSMC3IP FAM111B

9.76e-05193213ecbe1bd16df547427da5e69a3017300e766c2899
Drugcholine

PLCB1 PLCB4 DNMT1 SEC14L1 OSBPL2

8.99e-06320215CID000000305
DrugC10A

PLCB1 PLCB4

1.21e-056212CID000041624
DrugSKF83742

PLCB1 PLCB4

1.21e-056212CID000130828
Drug3-nitrocoumarin

PLCB1 PLCB4

3.63e-0510212CID002799766
Drugisopetasin

PLCB1 PLCB4

4.43e-0511212CID005318627
DrugAC1L1II7

PLCB1 PLCB4

5.32e-0512212CID000004589
Drugoxotremorine-M

PLCB1 FYN PLCB4

5.51e-0581213CID000004629
DrugDasatinib

ASPM FANCM PSMC3IP FYN FAM111B

6.15e-05478215ctd:D000069439
DrugAC1MQNLW

PLCB1 PLCB4

7.32e-0514212CID003504628
Drugm-3M3FBS

PLCB1 PLCB4

9.65e-0516212CID000761523
Drugsapintoxin A

PLCB1 PLCB4

1.37e-0419212CID000108085
Diseaseacute myeloid leukemia (is_marker_for)

PLCB1 DNMT1

5.56e-0449212DOID:9119 (is_marker_for)
Diseaseinterleukin 12 measurement

ZNF462 EFCAB13

6.50e-0453212EFO_0004753
DiseaseMYELODYSPLASTIC SYNDROME

FANCM PLCB1

1.04e-0367212C3463824
DiseaseHereditary Diffuse Gastric Cancer

FYN SPZ1 DNMT1

1.13e-03293213C1708349
DiseaseStomach Neoplasms

FYN SPZ1 DNMT1

1.17e-03297213C0038356
DiseaseMalignant neoplasm of stomach

FYN SPZ1 DNMT1

1.21e-03300213C0024623
DiseaseCleft Palate

CHD1 PLCB4

1.51e-0381212C0008925
Diseasetyrosine measurement

FYN RPL29

2.47e-03104212EFO_0005058
Diseasecardiovascular disease

PLCB1 DNMT1 EFCAB13

3.99e-03457213EFO_0000319
DiseaseBipolar Disorder

PLCB1 FYN DNMT1

4.50e-03477213C0005586
DiseaseColonic Neoplasms

PLCB1 DNMT1

5.19e-03152212C0009375
Diseasecolorectal cancer, colorectal adenoma

PLCB1 CHD1

5.19e-03152212EFO_0005406, MONDO_0005575

Protein segments in the cluster

PeptideGeneStartEntry
MKLKRHFVAQKYKKQ

ACSBG2

646

Q5FVE4
KKMHQGKKKKQNKNR

DNMT1

716

P26358
QNVRGMKKLDNYKKK

CHD1

341

O14646
HQQRQKYKKMKKAAV

ASPM

1596

Q8IZT6
KYKKMKKAAVIIQTH

ASPM

1601

Q8IZT6
ISKIKMNGKAYNKKT

QSER1

1631

Q2KHR3
QQGKIKEKMYGKQKI

PSMC3IP

56

Q9P2W1
NKYKMIHKTHKNINI

FANCM

1576

Q8IYD8
IMKLKNDKHLKNIYK

CCDC178

486

Q5BJE1
QKKGKYAQLIQKMHK

ABCC11

721

Q96J66
QIMKKLKHDKLVQLY

FYN

316

P06241
QVSKKQYNMNIKQHK

EFCAB13

936

Q8IY85
KLKEGHKKIYGKQSM

FAM111B

241

Q6SJ93
KIAMKQYTSNIKKGK

SEC14L1

146

Q92503
AKKHNKKGLKKMQAN

RPL29

46

P47914
AMNKVKKMKRYHVGK

HARS2

141

P49590
DLKQMKAYLKHLKKQ

PLCB4

921

Q15147
HIQDKNKKKLFMIYG

OSBPL2

286

Q9H1P3
QKSFVKLQKKHYKEM

PLCB1

916

Q9NQ66
RIIKHQKMYHKNNLK

ZNF462

176

Q96JM2
KKVEMYKQNKQAMKG

SPZ1

371

Q9BXG8
NLKAGHKNGKQKKMK

ZC3H8

131

Q8N5P1